SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (556)1/21/1998 3:19:00 AM
From: mike head  Read Replies (1) | Respond to of 1686
 
Hi, Rick, Yeh, I know about the genesis of your newsletter; it's been around a year or so. And, yeh, it's for Bio-freaks!And true, I'm pretty much a Lurker; I'm an architect, not a microbiologist, and an elderly autodidact. And, surprise, surprise, you'll find that two thirds+ of your subscribers will be, so called Lurkers! How will you inform us on "these threads"'about the advent? There are a lot of them, and SI won't tolerate its forum to be used as an advertising vehicle, nor would I respond to your message. Interesting logistical problem- little slack for 'Elitists"!There are surely an awesome number of people who follow you and Miljenko- two very bight guys- Your call... mch/pax et bonum



To: scaram(o)uche who wrote (556)1/25/1998 11:24:00 PM
From: William Nelson  Read Replies (1) | Respond to of 1686
 
off topic: Does anybody know anything about about Progenics?
It is recommended rather strongly in Forbes 1/12 issue. There's
not much on the web, and no discussion of it on SI, although I
started a thread on it.

They have a drug in phase III and another in I or II, a couple of
collaborations with big guys, and valuation isn't that high. I
don't see alot of downside, but it makes me nervous when no one is
talking about it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News